Clinical Trial Update: St. John's Wort in the Treatment of Raynaud's Phenomenon [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating St. John's Wort for Raynaud's phenomenon has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Raynaud Phenomenon

Drugs mentioned

• St. John's Wort (Hypericum perforatum)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Raynaud's Disease | Phase 3 | Status: COMPLETED